Glen Bradley - Net Worth and Insider Trading

Glen Bradley Net Worth

The estimated net worth of Glen Bradley is at least $3,712 dollars as of 2024-11-12. Glen Bradley is the Director of Alimera Sciences Inc and owns about 670 shares of Alimera Sciences Inc (ALIM) stock worth over $3,712. Details can be seen in Glen Bradley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Glen Bradley has not made any transactions after 2012-12-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Glen Bradley

To

Glen Bradley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Glen Bradley owns 2 companies in total, including Alimera Sciences Inc (ALIM) , and Refocus Group Inc (RFCS) .

Click here to see the complete history of Glen Bradley’s form 4 insider trades.

Insider Ownership Summary of Glen Bradley

Ticker Comapny Transaction Date Type of Owner
ALIM Alimera Sciences Inc 2012-12-13 director
RFCS Refocus Group Inc 2005-03-01 director

Glen Bradley Latest Holdings Summary

Glen Bradley currently owns a total of 1 stock. Glen Bradley owns 670 shares of Alimera Sciences Inc (ALIM) as of December 13, 2012, with a value of $3,712.

Latest Holdings of Glen Bradley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALIM Alimera Sciences Inc 2012-12-13 670 5.54 3,712

Holding Weightings of Glen Bradley


Glen Bradley Form 4 Trading Tracker

According to the SEC Form 4 filings, Glen Bradley has made a total of 0 transactions in Alimera Sciences Inc (ALIM) over the past 5 years. The most-recent trade in Alimera Sciences Inc is the acquisition of 670 shares on December 13, 2012, which cost Glen Bradley around $14,267.

Insider Trading History of Glen Bradley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Glen Bradley Trading Performance

GuruFocus tracks the stock performance after each of Glen Bradley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Glen Bradley is 110.64%. GuruFocus also compares Glen Bradley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Glen Bradley within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Glen Bradley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Glen Bradley

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 21.99 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 18.28 LIMIT LIMIT LIMIT LIMIT LIMIT

Glen Bradley Ownership Network

Ownership Network List of Glen Bradley

No Data

Ownership Network Relation of Glen Bradley

Insider Network Chart

Glen Bradley Owned Company Details

What does Alimera Sciences Inc do?

Who are the key executives at Alimera Sciences Inc?

Glen Bradley is the director of Alimera Sciences Inc. Other key executives at Alimera Sciences Inc include 10 percent owner Caligan Partners Lp , other: Chairman Emeritus C. Daniel Myers , and 10 percent owner David Edward Johnson .

Alimera Sciences Inc (ALIM) Insider Trades Summary

Over the past 18 months, Glen Bradley made no insider transaction in Alimera Sciences Inc (ALIM). Other recent insider transactions involving Alimera Sciences Inc (ALIM) include a net sale of 0 shares made by Caligan Partners Lp , and a net purchase of 1,401,901 shares made by Adam Morgan .

In summary, during the past 3 months, insiders sold 0 shares of Alimera Sciences Inc (ALIM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 579,000 shares of Alimera Sciences Inc (ALIM) were sold and 1,980,901 shares were bought by its insiders, resulting in a net purchase of 1,401,901 shares.

Alimera Sciences Inc (ALIM)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alimera Sciences Inc Insider Transactions

No Available Data

Glen Bradley Mailing Address

Above is the net worth, insider trading, and ownership report for Glen Bradley. You might contact Glen Bradley via mailing address: 2505 Anthem Village Dr, Suite E528, Henderson Nv 89052.